Literature DB >> 20558021

Autism spectrum disorders and epilepsy: moving towards a comprehensive approach to treatment.

Roberto Tuchman1, Michael Alessandri, Michael Cuccaro.   

Abstract

The biological and phenotypic heterogeneity of children with autism spectrum disorders (ASD) and epilepsy presents a significant challenge to the development of effective treatment protocols. There is no single treatment or treatment protocol for children with ASD or epilepsy. Children with co-occurring ASD and epilepsy should undergo a comprehensive assessment that includes investigation of underlying biological etiologies as well assessment of cognitive, language, affective, social and behavioral function prior to initiating treatment. The comprehensive treatment of children with ASD is based on a combination of therapeutic psychosocial interventions in combination with pharmacological agents. A process-oriented approach to assessment and intervention allows careful analysis of the child's response to treatment such that treatment protocols may be revised secondary to any changes in developmental trajectory of the child with ASD and epilepsy. The possibility of developing pharmacological interventions that target both ASD and epilepsy awaits definitive evidence. The best hope for good developmental outcomes in children with ASD and epilepsy is early recognition and comprehensive treatment of both the ASD and epilepsy.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20558021     DOI: 10.1016/j.braindev.2010.05.007

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  24 in total

1.  Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder.

Authors:  Weerasak Chonchaiya; Jacky Au; Andrea Schneider; David Hessl; Susan W Harris; Meredith Laird; Yi Mu; Flora Tassone; Danh V Nguyen; Randi J Hagerman
Journal:  Hum Genet       Date:  2011-10-15       Impact factor: 4.132

2.  In search of epilepsy biomarkers in the immature brain: goals, challenges and strategies.

Authors:  Aristea S Galanopoulou; Solomon L Moshé
Journal:  Biomark Med       Date:  2011-10       Impact factor: 2.851

Review 3.  Autism spectrum disorder and epilepsy: Disorders with a shared biology.

Authors:  Bo Hoon Lee; Tristram Smith; Alex R Paciorkowski
Journal:  Epilepsy Behav       Date:  2015-04-19       Impact factor: 2.937

Review 4.  Childhood epilepsy and autism spectrum disorders: psychiatric problems, phenotypic expression, and anticonvulsants.

Authors:  Sally J Robinson
Journal:  Neuropsychol Rev       Date:  2012-08-09       Impact factor: 7.444

Review 5.  Epilepsy and autism: is there a special relationship?

Authors:  Anne T Berg; Sigita Plioplys
Journal:  Epilepsy Behav       Date:  2012-02-29       Impact factor: 2.937

Review 6.  The role of glutamate and its receptors in autism and the use of glutamate receptor antagonists in treatment.

Authors:  Donald C Rojas
Journal:  J Neural Transm (Vienna)       Date:  2014-04-22       Impact factor: 3.575

Review 7.  [Psychopharmacology of autism spectrum disorders].

Authors:  L Poustka; T Banaschewski; F Poustka
Journal:  Nervenarzt       Date:  2011-05       Impact factor: 1.214

8.  A Profile on Emergency Department Utilization in Adolescents and Young Adults with Autism Spectrum Disorders.

Authors:  Guodong Liu; Amanda M Pearl; Lan Kong; Douglas L Leslie; Michael J Murray
Journal:  J Autism Dev Disord       Date:  2017-02

Review 9.  Autism Spectrum Disorder and Epilepsy: Two Sides of the Same Coin?

Authors:  Shafali Spurling Jeste; Roberto Tuchman
Journal:  J Child Neurol       Date:  2015-09-14       Impact factor: 1.987

10.  Predictors of trajectories of epilepsy-specific quality of life among children newly diagnosed with epilepsy.

Authors:  Rachelle R Ramsey; Kristin Loiselle; Joseph R Rausch; Jordan Harrison; Avani C Modi
Journal:  Epilepsy Behav       Date:  2016-03-12       Impact factor: 2.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.